A meta-analysis of 11 studies involving 1,020 rectal cancer patients revealed no significant differences in functional outcomes between transanal total mesorectal excision (taTME) and laparoscopic total mesorectal excision (LaTME). Measures of bowel, anorectal, and urogenital function, assessed through various scales like LARS and EORTC QLQ-C30/29, indicated similar results. These findings support the notion that both […]
Category: General Surgery
Prevalence of pouch fistulas post-restorative proctocolectomy is low
A systematic review and meta-analysis of 33 studies revealed a pooled prevalence of pouch fistulas at 0.05, with pouch failure rates in fistula patients at 0.24. The prevalence of developing a pouch fistula at 3, 5, and more than 5 years was similarly low, at 0.04, 0.05, and 0.05, respectively. These findings may guide future […]
Fidaxomicin demonstrates lower recurrence rates than vancomycin.
Findings indicate that fidaxomicin and vancomycin have no significant differences in overall treatment efficacy for Clostridium difficile infection (CDI). However, fidaxomicin significantly reduced recurrence rates at 40-day (RR=0.52), 60-day (RR=0.38), and 90-day (RR=0.62) intervals compared to vancomycin. Vancomycin was shown to be more effective for severe CDI cases. In terms of long-term mortality, fidaxomicin also […]
Body composition changes during therapy influence pancreatic cancer survival.
A study involving 138 pancreatic cancer patients revealed that increases in muscle mass (over 5%) and adipose tissue (over 15%) during neoadjuvant therapy were linked to improved survival rates (hazard ratios of 0.352 and 0.375, respectively). Conversely, a loss of visceral fat exceeding 15% adversely affected survival (hazard ratio of 1.853). Notably, dynamic anthropometric analysis […]
International consensus achieved on synoptic operative report for rectal prolapse
A consensus-derived synoptic operative report for rectal prolapse surgery was developed through a Delphi process involving 176 surgeons worldwide. Out of 30 initial descriptors, 16 reached over 70% agreement, including key variables such as surgery type and mesh used. This accomplishment will standardize operative reporting, enhance clinical communication, and potentially improve quality measures in rectal […]
Metabolic and bariatric surgery significantly reduces insulin dependency in diabetes.
In a study of 287 patients with insulin-treated type 2 diabetes, metabolic and bariatric surgery (MBS) showed remarkable efficacy. At five years post-surgery, insulin dependence dropped from complete dependency to 36.2%, and the use of non-insulin antidiabetic drugs decreased from 79.4% to 26.1%. Additionally, type 2 diabetes remission rates were highest after biliopancreatic diversion with […]
Self-care strategies enhance well-being in surgeons.
A structured self-care approach focusing on sleep, nutrition, and exercise can significantly reduce stress among surgeons, improving overall well-being and life quality. Key findings highlight the importance of consistent sleep for hormonal balance, balanced nutrition for metabolic health, and a regimen of 80% low-intensity and 20% high-intensity exercise. By prioritizing these elements, surgeons can enhance […]
Total Mesogastric Excision Shows Promising Short-Term Outcomes
A study examining total mesogastric excision (TME) for gastric cancer found that it results in significantly lower mean blood loss and a higher number of metastatic lymph nodes compared to standard D2 lymphadenectomy. With 37 patients involved, initial findings suggest TME offers advantages in peroperative and short-term outcomes, potentially improving disease-free survival. Conducted in Istanbul, […]
Neoadjuvant treatment improves survival in esophageal cancer patients
A retrospective analysis involving 645 patients with cT2 staged adenocarcinomas indicated that neoadjuvant treatment followed by surgery (nat/s) yields significantly better overall survival compared to primary surgery (ps). Median overall survival was 114.0 months for nat/s versus 51.0 months for ps in the cT2cnany cohort. Additionally, nat/s was associated with improved disease-free survival in cT2cn0 […]
Adrenalectomy shows promising survival rates for metastatic patients
A population-based analysis of 2,515 patients undergoing adrenalectomy for metastatic cancer revealed a one-year survival rate of 84.3%. Thirty-day mortality and morbidity rates were low at 1.3% and 29.9%, respectively. The study highlighted that prior radiotherapy correlated with increased complication rates. Laparoscopic procedures comprised 85.3%, maintaining resection completeness at 92.9%. Factors like extra-adrenal metastases and […]